| Cat.No. | Name | Information |
|---|---|---|
| M10249 | Teduglutide | Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome. |
| M45167 | Liraglutide | Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that may be used in studies related to type 2 diabetes. |
| M31369 | Beinaglutide TFA | Beinaglutide TFA is a recombinant human GLP-1 (rhGLP-1) peptide and a GLP-1R agonist that can be used in studies related to obesity and non-alcoholic steatohepatitis (NASH). |
| M31345 | Glepaglutide | Glepaglutide is a novel, long-acting glucagon-like peptide-2 (GLP-2) analog and a potent GLP-2R agonist. Glepaglutide is used in studies related to inflammatory bowel disease (IBD) and Crohn's disease. |
| M31031 | Apraglutide TFA | Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum. |
| M28126 | Apraglutide | Apraglutide (FE 203799) is a potentially best-in-class, potent, synthetic 33-amino acid peptide and long-acting GLP-2 analog that can be used in studies related to short bowel syndrome (SBS). |
| M27757 | GLP-1(7-36), amide TFA | GLP-1(7-36), amide TFA is a physiological incretin hormone that stimulates insulin secretion. |
| M25593 | PF-07081532 | PF-07081532 is a next-generation orally active GLP-1 receptor agonist. |
| M25390 | Dapiglutide | Dapiglutide (ZP7570) is a long-acting glucagon-like peptide-1 receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP-2R) dual agonist. |
| M21658 | Taspoglutide | Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist developed for treatment of type 2 diabetes, with an EC50 value of 0.06 nM. |
| M21371 | Tirzepatide | Tirzepatide (LY3298176) is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist with potential use in type 2 diabetes research. |
| M21288 | LY3502970 | LY3502970 (GLP-1 receptor agonist 1) is an orally active glucagon-like peptide (GLP-1) receptor partial agonist for studies related to type 2 diabetes and obesity. |
| M13970 | Lixisenatide acetate | Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). |
| M13968 | GLP-1(7-36), amide acetate | GLP-1(7-36), amide acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells. |
| M13967 | GLP-1(7-37) acetate | GLP-1(7-37) acetate is an intestinal insulinotropic hormone that augments glucose induced insulin secretion. |
| M11319 | GLP-1(7-36), amide TFA | TFA is a major intestinal hormone that stimulates insulin secretion by pancreatic beta cells in response to glucose. |
| M11207 | GLP-1(7-37) | Glp-1 (7-37) is an intestinal insulin hormone that enhances glucose-induced insulin secretion. |
| M10802 | Exenatide Acetate (Exendin-4) | Exenatide Acetate (Exendin-4) is a first-in-class glucagon-like peptide 1 (GLP-1) receptor agonist consisting of 39 amino acids. |
| M10311 | Danuglipron (PF-06882961) | Danuglipron (PF-06882961) is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R) agonist. |
| M10089 | Avexitide (Exendin 9-39) | Avexitide (Exendin 9-39) is a specific and competitive GLP-1 receptor antagonist. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
